Physician profile
Jamie Lee Settle
NPI 1497749766
$393.11
in general payments reported to CMS, 2019-2025
11 companies · $13.49 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $209 · 2022: $58.58 · 2023: $78.56 · 2024: $33.61 · 2025: $13.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $125.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $142.59 | 2021-2023 | |
| Amgen INC. | $77.46 | 2021 | |
| Janssen Biotech, INC. | $29.37 | 2021 | |
| Abbvie INC. | $28.04 | 2021 | |
| Ucb, INC. | $27.60 | 2021 | |
| Merck Sharp & Dohme LLC | $19.86 | 2024 | Keytruda, Lynparza |
| Kowa Pharmaceuticals America, INC. | $14.23 | 2022 | |
| Organogenesis INC. | $13.75 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $13.56 | 2023 | Dupixent |
| Medtronic, INC. | $13.49 | 2025 | Truclear |
| Genzyme Corporation | $13.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Settle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.